Chargement en cours...
Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis
A number of factors have been identified that increase the risk of HCC. Recently it has become appreciated that type II diabetes increases the risk of developing HCC. This represents a patient population that can be identified and targeted for cancer prevention. The biguanide metformin is a first li...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3324649/ https://ncbi.nlm.nih.gov/pubmed/22467080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-11-0228 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|